Cynthia Lynn Anderson's most recent trade in VistaGen Therapeutics Inc was a trade of 6,617 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 30 Jun 2025 | 6,617 | 12,801 (0%) | 0% | 1.7 | 11,249 | Common Stock |
| VistaGen Therapeutics Inc | Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 2.51 per share. | 31 Dec 2024 | 2,592 | 6,184 (0%) | 0% | 2.5 | 6,499 | Common Stock |
| VistaGen Therapeutics Inc | Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 2.96 per share. | 28 Jun 2024 | 3,592 | 3,592 (0%) | 0% | 3.0 | 10,625 | Common Stock |
| VistaGen Therapeutics Inc | Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| VistaGen Therapeutics Inc | Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2023 | 8,333 | 8,333 | - | - | Stock Option (right to buy) |